Qin Hu

Nanjing Medical University

Papers

1

Total Citations

16

H-Index

1

About

Qin Hu is a rising star in the field of biosensing and molecular diagnostics, with a research focus on CRISPR/Cas12a-based technologies and their innovative applications. Her most-cited work, "DNA Robots for CRISPR/Cas12a Activity Management and Universal Platforms for Biosensing" (2024, 16 citations), addresses a critical challenge in the field: precisely controlling the trans-cleavage activity of Cas12a. While traditional methods for managing Cas12a activity are often cumbersome, Hu’s pioneering approach introduces DNA robots as a simple, elegant solution to regulate this powerful enzyme. This breakthrough not only enhances the versatility of CRISPR-based biosensors but also paves the way for universal platforms that can detect a wide range of targets with high sensitivity and specificity. Hu’s work stands out for its ingenuity in merging DNA nanotechnology with CRISPR systems, offering a transformative tool for point-of-care diagnostics. With her contributions already garnering attention, Qin Hu is establishing herself as a key innovator in next-generation biosensing, promising to revolutionize how we approach molecular detection and disease monitoring.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
DNA Robots for CRISPR/Cas12a Activity Management and Universal Platforms for Biosensing
16 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Nanjing Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago